Voglibose suppliers

Voglibose

CAS:: 83480-29-9

MF:: C10H21NO7

MW:: 267.28

SecurityInformation

Symbol(GHS) ：: GHS07

Signal word ：: Warning

Hazard statements ：: H302-H315-H319-H335

Precautionary statements ：: P261-P305+P351+P338

Hazard Codes ：: Xi

Risk Statements ：: 20/21/22-36/37/38

Safety Statements ：: 36/37-37/39-26

WGK Germany ：: 3

RTECS ：: NM7524600

HS Code ：: 2940.00.6000

Use：: Voglibose was introduced in Japan for the treatment of postprandial hyperglycemia in diabetic patients. As an orally active α-D-glucosidase inhibitor, it is effective in decreasing the release of glucose from carbohydrate ingestion and slowing the increase of postprandial blood glucose levels, as demonstrated in animals and humans following sucrose and starch loading. In addlion, voglibose was reported to have prophylactic effect in genetically obese Wistar rats, maintaining low plasma levels of glucose, triglyceride and insulin, indicating a potential usefulness for the management of other carbohydrate-dependent metabolic disorders such as obesity. Voglibose is much more potent and has fewer side effects than acarbose, another agent in its class.

More▼

You can find Voglibose suppliers, manufacturers, and distributors from countries such as CHINA, India and the United States here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.

Hebei Weibang Biotechnology Co., Ltd